In this post, we use our CapexData analytics portal to analyse the broader UK capex project picture in 2026. The UK has had a turbulent year by many measures. By looking at the detailed picture for the process manufacturing sectors (you can look back at our sector outlook posts on our blog), there are many Continue reading
The European pharmaceutical capex outlook for 2026 is more restrained than twelve months ago, but there remains meaningful opportunity for suppliers of capital equipment and machinery. While the exceptional conditions of 2024 have eased, the market continues to generate a steady flow of investment, with regional nuances shaping where the best commercial prospects lie. European Continue reading